Generic Name and Formulations:
Hydroquinone 2%, ethyldihydroxypropyl PABA 5%, dioxybenzone 3%, oxybenzone 2%; crm; contains sulfites.
Valeant Pharmaceuticals, Inc
Indications for SOLAQUIN:
Hyperpigmented skin conditions.
Apply and massage in twice daily; max 2 months.
Avoid eyes. Use cautiously near lips, eyes, nose. Do 24 hr patch test before use; do not use if itching, vesicle formation, or excessive inflammatory response occurs. Close patient supervision recommended. Discontinue if sensitization occurs. Asthma. Avoid sun or UV light. Pregnancy (Cat.C). Nursing mothers.
Depigmenting agent + sunscreens.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- Prevalence of Major Depressive Disorder Remains High In US Population
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Triiodothyronine in the Treatment of Bipolar Depression
- Suicide Risk After Self-Harm Among Adolescents, Young Adults
- E-Cigarettes Associated With More Harms Than Benefits at Population Level
- Safety, Efficacy of Deep Brain Stimulation for Alzheimer Disease Examined
- Many Teens Who Use Tobacco Don't Self-Identify as Users